
Loading, please wait...

Loading, please wait...

Recent research highlights a significant breakthrough regarding the PBX1 variant 46,XY DSD connection. The pre-B cell leukemia transcription factor (PBX1) is vital during human embryonic development. Mutations in this gene often lead to complex clinical presentations. In this specific case, researchers identified a novel missense variant, c.710G>C (p.R237T), in a Taiwanese girl with 46,XY Differences of Sex Development (DSD). Consequently, this finding provides new insights into the genetic landscape of gonadal dysgenesis and sexual development.
The study utilized functional validation to assess the impact of the p.R237T variant. Compared to wild-type PBX1, the mutated protein exhibited significantly reduced stability. Furthermore, the variant hampered nuclear translocation within HEK293 cells. This disruption is critical because PBX1 must enter the nucleus to regulate gene expression properly. Additionally, RNA sequencing revealed alterations in several DSD-related genes, such as MAP3K4 and EMX2. Therefore, these molecular changes likely contribute to the undervirilized genitalia and mixed gonadal differentiation observed in the patient.
Identifying the PBX1 variant 46,XY DSD helps clinicians better understand the molecular mechanisms of sexual development. Although the role of PBX1 in the gonads was previously elusive, this case underscores its importance in differentiation. Consequently, genetic testing for PBX1 variants should be considered in syndromic DSD cases. Furthermore, early diagnosis through whole-exome sequencing allows for more personalized clinical management. This advancement ultimately improves our ability to counsel families regarding genetic risks and developmental outcomes in pediatric endocrinology.
The p.R237T variant reduces protein stability and prevents the PBX1 protein from moving into the cell nucleus. This prevents it from correctly regulating genes necessary for normal sexual development.
The patient presented with 46,XY DSD, characterized by severely undervirilized genitalia and gonadal dysgenesis featuring both ovarian and testicular differentiation.
PBX1 acts as a transcription factor expressed throughout embryonic stages. It plays a crucial role in organogenesis, and its variants are increasingly linked to diverse developmental conditions, including DSD.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
Tsai MC et al. Functional validation of a novel PBX1 missense variant in a 46,XY girl. Sex Dev. 2026 Feb 26. doi: 10.1159/000550575. PMID: 41746858.
Ferraz-de-Souza B, et al. Transcription factors and the genetic control of sexual differentiation. Mol Cell Endocrinol. 2011.
Kopp MC, et al. PBX1 in human development and disease. Journal of Medical Genetics. 2021.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A novel PBX1 variant (p.R237T) is linked to 46,XY DSD, causing reduced protein stability and impaired nuclear translocation in gonadal differentiation....
7 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today